| Literature DB >> 35923195 |
Yuan He1, Lin Li2, Hao Chang3, Bin Cai4, Huajun Gao4, Guoyu Chen1, Wen Hou2, Zubaydan Jappar2, Yizhe Yan1.
Abstract
Dendrobium officinale Kimura et Migo (D. officinale) is a traditional medicinal and food homologous plant that has been used for thousands of years in folk medicine and nutritious food. Recent studies have shown that polysaccharide is one of the main biologically active components in D. officinale. D. officinale polysaccharides possess several biological activities, such as anti-oxidant, heptatoprotective, immunomodulatory, gastrointestinal protection, hypoglycemic, and anti-tumor activities. In the past decade, polysaccharides have been isolated from D. officinale by physical and enzymatic methods and have been subjected to structural characterization and activity studies. Progress in extraction, purification, structural characterization, bioactivity, structure-activity relationship, and possible bioactivity mechanism of polysaccharides D. officinale were reviewed. In order to provide reference for the in-depth study of D. officinale polysaccharides and the application in functional food and biomedical research.Entities:
Keywords: Dendrobium officinale; biological activity; polysaccharides; structural characterization; structure-activity relationship
Year: 2022 PMID: 35923195 PMCID: PMC9339781 DOI: 10.3389/fnut.2022.965073
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
FIGURE 1Schematic representation of the extraction, purification, and bioactivity of polysaccharides from Dendrobium officinale.
The polysaccharides isolated from Dendrobium officinale.
| No. | Compound name | Source | Mw (Da) | Monosaccharide composition | Structures | Biological activities | References |
| 1 | DOP-W3-b | Stems of | 1.543 × 104 | Man, Glc in the ratio of 4.5:1.0 | Backbone consisting of β-(1→4)-D-Man | Immunoregulation |
|
| 2 | DPOa |
| 8.1 × 105 | Man, Glc in the ratio of 5.6:1.0 | Backbone consisting of β-(1→4)-D-Man | Immunoregulation |
|
| 3 | DOPb |
| 6.7 × 105 | Man, Glc in the ratio of 5.9:1.0 | Backbone consisting of β-(1→4)-D-Man | Immunoregulation | |
| 4 | DOP | Stems of | 8.5 × 103 | Man, Glc, Ara, GalA in the ratio of 6.2:2.3:2.1:0.1 | Backbone consisting of β-(1→4)-D-Man | Antioxidant |
|
| 5 | HPS-1B23 | Herba | 2.2 × 104 | Glc, Man, Gal in the ratio of 31:10:8 | Backbone consisting of α-(1→6)-D-Glu | Immunoregulation |
|
| 6 | FP |
| 2.53 × 103 | Glc, Gal, Man in the ratio of 2.1:3.4:3.9 | Backbone consisting of →3,6)-β-L-Man | Antioxidant, immunoregulation |
|
| 7 | DOPS-1 |
| 1.57 × 106 | Backbone consisting of (1→4)-β-D-Glc | Antioxidant, antitumor |
| |
| 8 | DDFPs50 |
| 5.63 × 105 | Man, Glc, Gal, Rha, Ara, Fru, GlcA in the ratio of 8.45:2.93:1.00:0.06:0.37:0.04:0.2 | Antioxidant |
| |
| 9 | DOPA-1 | 2.29 × 105 | Man, Glc, Gal in the ratio of 1:0.42:0.27 | contain (1 → 3), (1 → 2), and (1 → 6) linkages in the main or branch chains | Anti-tumor |
| |
| 10 | DOPA-1 | Fresh stems of | 3.94 × 105 | Man, Glc in the ratio of 5.8:1 | Backbone consisting of β-(1→4)-D-Man | Antioxidant, immunoregulation |
|
| 11 | DOPA-2 | Fresh stems of | 3.62 × 105 | Man, Glc in the ratio of 4.5:1 | Backbone consisting of β-(1→4)-D-Man | Antioxidant, immunoregulation | |
| 12 | DOP-1 |
| 6.8 × 103 | Man, Glc in the ratio of 5.18:1 | Backbone consisted of →4)-β-D-Glc | Hypoglycemic |
|
| 13 | DOP-2 |
| 1.43 × 104 | Man, Glc in the ratio of 4.78:1 | Backbone consisted of →4)-β-D-Glc | Hypoglycemic | |
| 14 | DLP- 1 | 1.38 × 106 | Man, Glc in the ratio of 3.13:1 | Backbone consisted of (1→4)-β-D- Man | Immunoregulation |
| |
| 15 | DLP- 2 | 1.93 × 106 | Rha, Ara, Gal in the ratio of 1.37:0.94:1 | Backbone consisted of (1→4)-β-D-Man | Immunoregulation | ||
| 16 | DOP1-1 |
| 1.78 × 105 | Man, Gal in the ratio of 5.9:1 | Immunoregulation |
| |
| 17 | DCP | Fresh | 2.21 × 105 | Glc, Man, GalA in the ratio of 30.2:69.5:0.3 | Backbone consisted of (1→4)-β-D-Man | Immunoregulation |
|
| 18 | LDOP | Leaf of | 9.18 × 104 | Man, Gla, Glc, GlcA, and Ara in the ratio of 2.0:1.3:1.6:1.7:0.7 | Backbone consisting of α-(1→4)-D-Man | Anti-inflammatory |
|
| 19 | DOA1a | Dried stems of | 3.7 × 104 | Ara, Xyl, Glc, 4- | Backbone consisting of β-(1→4)-D-xylan; branch consisting of α-(1→4)-D-Glc | Anti-angiogenesis |
|
| 20 | DOP-1 | 4.47 × 105 | Gal, Glc, Man in the ratio of 1:1.79:6.71 | Backbone consisting of →4)-α-D-Glc | Antioxidant, anti-tumor |
|
FIGURE 2The chemical structure of D. officinale polysaccharides. (A) The D. huoshanense polysaccharide (HPS-1B23), (B) two component polysaccharides (DOP-1, DOP-2), (C) a novel polysaccharide (S32), (D) two novel polysaccharide fractions (DOW-1, DOPW-2).
FIGURE 3Bioactivities of D. officinale polysaccharides.
FIGURE 4The potential immunomodulatory mechanisms of D. officinale.
FIGURE 5The potential anti-tumor mechanisms of D. officinale.
FIGURE 6The potential hypoglycemic mechanisms of D. officinale.